AI Summary Primary sclerosing cholangitis recurs in 20–30% of patients after liver transplant, and hepatitis B and hepatitis C can also return without prevention and treatment.
Medically reviewed.
Recurrence means the disease that damaged your original liver comes back in your transplanted liver. A transplant replaces the liver, but it does not remove the cause of every liver disease. For example, a transplant does not cure hepatitis C, and the virus can affect the new liver unless it is treated.
Not every disease returns, and care teams have ways to lower the risk. This page explains which conditions can come back, which tests and warning signs to know, how recurrence is prevented and managed, and when to call your transplant team.
Liver Health AI Assistant
Ask Aimy
Aimy answers from LiverDirectory’s reviewed health information — helping patients make sense of liver-health terms, prepare for specialist visits, and explore what to look up next.
About recurrence
Recurrence means the disease that damaged your first liver returns in your transplanted liver, also called the graft. A transplant replaces the diseased organ. It does not always remove the cause of the disease.
Hepatitis C is one example. A liver transplant does not cure it, and the infection can harm the healthy new liver. For this reason, antiviral treatment continues after transplant.
Recurrence is different from rejection. Rejection is your immune system reacting to the new liver. Recurrence is the original disease coming back. Your team watches for both with regular lab tests.
What you may notice
Recurrence does not always cause symptoms early on, so lab tests matter. Signs of liver trouble can be mild at first. Your transplant team can tell you whether they point to recurrence, rejection, or another cause.
Getting checked
After transplant, lifelong monitoring includes immunosuppressive therapy, laboratory testing, and surveillance for complications or recurrence. Which tests you need depends on the disease that led to your transplant.
Blood tests can show a problem before you feel symptoms. Keep every lab and clinic appointment, even when you feel well.
Care and prevention
Prevention and treatment depend on the disease that led to your transplant. Your transplant team chooses the plan.
Direct-acting antivirals (DAAs) are interferon-free regimens that are better tolerated than older treatments. Treating hepatitis C while a person is on the waiting list can clear the virus and prevent infection of the new liver. Antiviral treatment also continues after transplant.
Hepatitis B immunoglobulin (HBIG) plus antiviral medicine is very successful at preventing hepatitis B from coming back. Lowering the viral load before surgery also reduces the risk. With these tools, hepatitis B is no longer a reason to rule out a transplant.
PSC is a long-term disease of the bile ducts, the small tubes that carry bile out of the liver. Inflammation and scarring narrow the ducts over time, and PSC can return in the new liver, recurring in 20–30% of patients after transplant. No single test settles the question, so your team looks at several things together, such as blood tests that show a bile-duct pattern (raised ALP and GGT) and an MRI of the bile ducts called MRCP that can show narrowing.
Lifelong monitoring after transplant includes surveillance for recurrence. If cancer returns, your care team will discuss the options that fit your situation.
No single plan fits every disease. Take your medicines as prescribed and keep every follow-up visit.
What influences recurrence
Recurrence depends mainly on the disease that caused your liver failure.
Recurrence risk depends on your original diagnosis. Ask your transplant team how likely your disease is to return and what you can do to lower the risk.
When to get checked
Contact your transplant team if something feels different. Early checks give your team the best chance to act before a problem grows.
Call your team if you notice a fever, swelling, nausea, new or worsening yellowing of the skin or eyes, pale stools, or a change in your energy. Also call if you have confusion or unusual bruising or bleeding. Do not wait for your next scheduled visit.
Blood work can show changes before you feel anything. Go to follow-up visits and lab appointments even when you feel fine, and review the results with your team afterward.
Ask what disease caused your transplant, how likely it is to return, which tests will watch for it, and what prevention medicine you need. Write the answers down.
Find doctors who treat liver transplant recipients and connect with a specialist near you.
Eating Habits After Transplant
Healthy habits support your new liver. A liver-friendly routine of fresh, simple meals, daily movement, and good rest helps your recovery and your overall transplant health.
Take your medicines as prescribed, even when nothing feels wrong. Ask your transplant team for diet advice that fits your medicines and health conditions.
Healthy Habit Steps
Common questions
Recurrence means the disease that damaged your first liver returns in your transplanted liver, also called the graft. It happens because a transplant replaces the liver but does not always remove the cause of the disease. Hepatitis C is one example. A transplant does not cure the virus, so it can harm the new liver unless it is treated. Recurrence does not happen with every disease, and your team has ways to lower the risk.
Hepatitis C, hepatitis B, primary sclerosing cholangitis (PSC), and liver cancer (hepatocellular carcinoma, or HCC) can all return. PSC recurs in 20–30% of patients after transplant. Hepatitis B is more likely to return when the viral load is high at the time of surgery. Your own risk depends on the disease that caused your liver failure, so ask your transplant team how likely it is to return in your case.
No. Rejection is your immune system reacting to the new liver. Recurrence is the original disease coming back. Both can raise liver enzymes on blood tests, and both can cause similar symptoms such as tiredness or nausea. Your team looks at your lab results, symptoms, and history together to tell them apart. Do not try to decide on your own which one is happening.
Often, yes, but prevention depends on your diagnosis. Hepatitis B immunoglobulin (HBIG) plus antiviral medicine is very successful at preventing hepatitis B from coming back, and lowering the viral load before surgery also helps. Treating hepatitis C while you are on the waiting list can clear the virus and protect the new liver, and antiviral treatment continues after transplant. Taking your medicines as prescribed and keeping every follow-up visit are the most important steps you can take.
Blood tests are the main tool. They check liver enzymes (ALT and AST) and how well your liver is working. If you had hepatitis B or C, your team also measures the virus in your blood with viral load tests. If you had liver cancer, your team adds surveillance for cancer coming back and sets the schedule. Which tests you need depends on the disease that led to your transplant.
Call your team if you have a fever, swelling in your legs or belly, nausea, a change in your energy, or yellowing of your skin or eyes. Also call for pale or clay-colored stools, confusion, or unusual bruising or bleeding. Do not wait for your next scheduled visit. These signs can have many causes, including recurrence, rejection, and infection, so your team needs to check you. A notebook or phone app for symptoms and questions can help you describe changes clearly.
Yes. Lifelong monitoring after transplant includes immunosuppressive therapy, laboratory testing, and surveillance for complications or recurrence. In the first couple of years you will have frequent lab tests and close follow-up. Go to every visit, even when you feel well, because blood work can show a problem before you notice symptoms.
Medical disclaimer: LiverDirectory provides educational information and a directory of providers. It does not provide medical advice, diagnosis, or treatment. Always consult a licensed physician regarding any medical condition.
